9th Circuit reverses denial of disability benefits for a woman whose migraines were improperly discounted…

Record source: CourtListener

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 15 2026 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT GRISELDA BRAMBILA, No. 25-1989 Plaintiff - Appellant, D.C. No. 1:23-cv-03124-LRS v. FRANK BISIGNANO, Commissioner of MEMORANDUM* Social Security, Defendant - Appellee. Appeal from the United States District Court for the Eastern District of Washington Lonny R. Suko, District Judge, Presiding Argued and Submitted April 24, 2026 Seattle, Washington Before: W. FLETCHER and KOH, Circuit Judges, and RAYES, District Judge.** Griselda Brambila appeals from the district court’s order affirming an Administrative Law Judge’s (ALJ) denial of her application for supplemental security income under Title XVI of the Social Security Act. We have jurisdiction * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable Douglas L. Rayes, United States District Judge for the District of Arizona, sitting by designation. under 28 U.S.C. § 1291. We reverse the district court’s decision and remand with instructions to remand to the ALJ for the calculation and award of benefits. “The [ALJ’s] disability determination should be upheld unless it contains legal error or is not supported by substantial evidence.” Orn v. Astrue, 495 F.3d 625, 630 (9th Cir. 2007). Substantial evidence is more than a scintilla, less than a preponderance, and relevant evidence that a reasonable person might accept as adequate to support a conclusion considering the whole record. Id. Brambila contends that the ALJ erred in evaluating various medical source opinions and assessing the limiting effects of her impairments, including her migraines and psychogenic non-epileptic seizures (PNES). We conclude that the ALJ materially erred in assessing Brambila’s migraines and PNES, and that these errors alone warrant remanding for the calculation and award of benefits. We therefore do not reach Brambila’s other arguments. 1. The ALJ improperly discounted Brambila’s allegations concerning the frequency and severity of her migraines. Proper evaluation of a claimant’s symptom allegations requires the ALJ to perform a two-step analysis. Garrison v. Colvin, 759 F.3d 995, 1014 (9th Cir. 2014). “First, the ALJ must determine whether the claimant has presented objective medical evidence of an underlying impairment which could reasonably be expected to produce the pain or other symptoms alleged.” Id. (internal quotation marks and citations omitted). If the 2 25-1989 claimant presents such evidence “and there is no evidence of malingering, the ALJ can reject the claimant’s testimony about the severity of her symptoms only by offering specific, clear and convincing reasons for doing so.” Id. at 1014–15 (internal quotation marks and citations omitted). In response to a September 2018 questionnaire, Brambila reported that she began experiencing migraines following a car accident in 2007. These migraines caused nausea, vision changes, throbbing pain, and sensitivity to light and sound. She reported that they occurred about fourteen times per month without medication, but only two to four times per month with medication, although even with medication they would last two to four days each. During her first administrative hearing in June 2020, Brambila testified that she would have “maybe one [migraine] a month” with medication. During her second administrative hearing in March 2023, Brambila testified that, when taking topiramate, she experienced about two migraines per month lasting at least two days each. The ALJ found that Brambila’s medically determinable impairments could reasonably be expected to cause her symptoms and did not find Brambila malingered. But the ALJ found Brambila’s migraines were not as limiting as she claimed because of three perceived “inconsistencies in the record.” 3 25-1989  First, the ALJ observed that Brambila worked during the time she reported experiencing migraines, suggesting they are not as limiting as she describes. This reason lacks substantial evidentiary support. Brambila’s earning records reflect little to no income during this period. That Brambila could perform some sporadic, insubstantial work during this time does not undermine her testimony. Next, the ALJ noted that Brambila alleges her migraines cause memory problems, but no memory problems are documented in the medical record. Although the ALJ provided a sufficiently supported reason for discounting Brambila’s claim that her migraines caused memory issues, this reason does not justify discounting Brambila’s testimony that her migraines occurred up to twice a month and lasted at least two days at a time. Finally, the ALJ remarked that the treating records “do not document migraines, or headaches, of the frequency [Brambila] has described.” But the ALJ did not support this finding with substantial evidence in the record. Instead, the ALJ isolated two pages of the record to support her conclusion: treatment notes from Brambila’s visits with her treating neurologist on June 9, 2020, and January 3, 2023, both of which state under the “History of Patient Illness” section that Brambila was taking topiramate in August 2018, which helped reduce her headaches to one or two per month of short duration. The ALJ, however, did not 4 25-1989 account for considerable evidence supporting Brambila’s allegations concerning the frequency and duration of her migraines. For example, when Brambila began seeing her treating neurologist in November 2017, she reported experiencing migraines more than fifteen days per month, with each migraine lasting two to four days. In August 2018, records show topiramate helped reduce her migraines to one or two mild headaches per month. The following month, however, Brambila reported that, even with medication, her migraines were occurring two to four times per month, each lasting for two to four days. In May 2019, progress notes indicate Brambila was experiencing four migraines per month even with topiramate, and that she was unhappy with the side effects of the medication. She had two migraines per month in November 2019, roughly one per month in 2020 and 2021, and up to two a month in 2022 and 2023. The totality of the record therefore paints a picture consistent with the thrust of Brambila’s testimony: her migraines worsened significantly in 2017; at times topiramate helped reduce their frequency to once or twice per month; but even with the medication, those monthly migraines could last for at least a day. The ALJ’s error in assessing Brambila’s testimony concerning the frequency and duration of her migraines was not harmless because a vocational expert testified that the “accepted norm within unskilled work” is no more than one missed day per month and no more than ten percent of the workday off-task. 5 25-1989 Someone experiencing severe migraines as often as Brambila claims would be unable to sustain a full-time unskilled job.

Official opinion source